前列腺癌
医学
荟萃分析
阉割
肿瘤科
癌症
内科学
激素
作者
Maria Luisa Garo,Petra Petranović Ovčariček,Stefano Fanti,Luca Giovanella
摘要
Approximately 10%-20% of prostate cancers progress to metastatic and castration-resistant forms (mCRPC). Radioligand (RLT) therapy with [
科研通智能强力驱动
Strongly Powered by AbleSci AI